The Frequency Of JAK2 V617F Gen Mutation And Its Associations With Whole Blood Count Parameters

IF 0.6 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Kübranur Ünal, S. Erdogan, F. Yilmaz
{"title":"The Frequency Of JAK2 V617F Gen Mutation And Its Associations With Whole Blood Count Parameters","authors":"Kübranur Ünal, S. Erdogan, F. Yilmaz","doi":"10.5505/TJB.2014.39206","DOIUrl":null,"url":null,"abstract":"Objective: V617F mutation of Janus kinase (JAK2) gene is used in the diagnosis of BCR-ABL negative myeloproliferative diseases such as polycytemia vera, essential thrombocythemia and primary myelofibrosis. In this study, we evaluated the frequency of JAK2 V617F mutation in a group of Turkish individuals and its association with whole blood count parameters. Methods: We retrospectively reviewed the records of 201 patients (174 males and 27 females) who were tested for JAK2 V617F mutation from January 2012 to December 2012. JAK2V617F mutation, BCR-ABL mutation, level of white blood cell count (WBC), red blood cell count (RBC), platelet count (PLT), red blood cell distribution width (RDW), hemoglobin (Hb), hematocrit (Hct), level of iron, iron binding capacity and demographic data of patients were also noted. A commercial kit assay for the identification of V617F mutation based on real time-polymerase chain reaction had been used to investigate mutation of the JAK2 gene. Results: 14.9 % of the 201 samples being investigated for JAK2 V617F mutation were positive. Patients who were ordered for JAK2 V617F mutation testing were divided into two groups according to mutation being positive and negative. Age, RDW and PLT levels were significantly higher in mutation positive group (p<0.05). Besides JAK2 V617F mutation, BCR-ABL mutation orders were examined and BCR-ABL mutation reports were also evaluated on subjects. Age, RDW and PLT were significantly higher in JAK2 V617F mutation positive / BCR-ABL mutation negative group (p<0.05). Conclusion: In this study significant differences for age, RDW and platelet count were determined in mutation positive subjects. Findings of this study suggest that JAK2 V617F mutation could cause proliferation of megakaryocytic cells as well as erythroid cells and as a result of disturbance in erythroid maturation process, the proliferation in the erythroid cells could cause an increase in RDW.","PeriodicalId":23355,"journal":{"name":"Turkish Journal of Biochemistry-turk Biyokimya Dergisi","volume":"8 1","pages":"93-98"},"PeriodicalIF":0.6000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Biochemistry-turk Biyokimya Dergisi","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.5505/TJB.2014.39206","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Objective: V617F mutation of Janus kinase (JAK2) gene is used in the diagnosis of BCR-ABL negative myeloproliferative diseases such as polycytemia vera, essential thrombocythemia and primary myelofibrosis. In this study, we evaluated the frequency of JAK2 V617F mutation in a group of Turkish individuals and its association with whole blood count parameters. Methods: We retrospectively reviewed the records of 201 patients (174 males and 27 females) who were tested for JAK2 V617F mutation from January 2012 to December 2012. JAK2V617F mutation, BCR-ABL mutation, level of white blood cell count (WBC), red blood cell count (RBC), platelet count (PLT), red blood cell distribution width (RDW), hemoglobin (Hb), hematocrit (Hct), level of iron, iron binding capacity and demographic data of patients were also noted. A commercial kit assay for the identification of V617F mutation based on real time-polymerase chain reaction had been used to investigate mutation of the JAK2 gene. Results: 14.9 % of the 201 samples being investigated for JAK2 V617F mutation were positive. Patients who were ordered for JAK2 V617F mutation testing were divided into two groups according to mutation being positive and negative. Age, RDW and PLT levels were significantly higher in mutation positive group (p<0.05). Besides JAK2 V617F mutation, BCR-ABL mutation orders were examined and BCR-ABL mutation reports were also evaluated on subjects. Age, RDW and PLT were significantly higher in JAK2 V617F mutation positive / BCR-ABL mutation negative group (p<0.05). Conclusion: In this study significant differences for age, RDW and platelet count were determined in mutation positive subjects. Findings of this study suggest that JAK2 V617F mutation could cause proliferation of megakaryocytic cells as well as erythroid cells and as a result of disturbance in erythroid maturation process, the proliferation in the erythroid cells could cause an increase in RDW.
JAK2 V617F基因突变频率及其与全血计数参数的关系
目的:将Janus kinase (JAK2)基因V617F突变应用于真性多细胞症、原发性血小板增多症、原发性骨髓纤维化等BCR-ABL阴性骨髓增生性疾病的诊断。在这项研究中,我们评估了一组土耳其个体中JAK2 V617F突变的频率及其与全血细胞计数参数的关系。方法:回顾性分析2012年1月至2012年12月进行JAK2 V617F突变检测的201例患者(男174例,女27例)的临床资料。还记录了JAK2V617F突变、BCR-ABL突变、白细胞计数(WBC)、红细胞计数(RBC)、血小板计数(PLT)、红细胞分布宽度(RDW)、血红蛋白(Hb)、红细胞压积(Hct)、铁水平、铁结合能力以及患者的人口统计学数据。基于实时聚合酶链反应的V617F突变鉴定试剂盒已用于研究JAK2基因的突变。结果:201份样本JAK2 V617F基因突变阳性率为14.9%。预定进行JAK2 V617F突变检测的患者根据突变阳性和阴性分为两组。突变阳性组患者年龄、RDW、PLT水平均显著升高(p<0.05)。除JAK2 V617F突变外,还检测了BCR-ABL突变顺序,并对受试者的BCR-ABL突变报告进行了评估。JAK2 V617F突变阳性/ BCR-ABL突变阴性组患者的年龄、RDW和PLT均显著升高(p<0.05)。结论:在本研究中,突变阳性受试者的年龄、RDW和血小板计数存在显著差异。本研究结果提示JAK2 V617F突变可引起巨核细胞和红细胞的增殖,并且由于红细胞成熟过程受到干扰,红细胞的增殖可引起RDW的增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.20
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊介绍: Turkish Journal of Biochemistry (TJB), official journal of Turkish Biochemical Society, is issued electronically every 2 months. The main aim of the journal is to support the research and publishing culture by ensuring that every published manuscript has an added value and thus providing international acceptance of the “readability” of the manuscripts published in the journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信